Sector
HealthcareOpen
₹22.5Prev. Close
₹22.95Turnover(Lac.)
₹1.35Day's High
₹23.45Day's Low
₹22.552 Week's High
₹41.1552 Week's Low
₹19.55Book Value
₹47.63Face Value
₹10Mkt Cap (₹ Cr.)
31.28P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 13.9 | 13.9 | 13.9 | 9.9 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 52.31 | 55.54 | 52 | 3.43 |
Net Worth | 66.21 | 69.44 | 65.9 | 13.33 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Revenue | 20.79 | 22.18 | 20.6 |
yoy growth (%) | -6.26 | 7.64 | |
Raw materials | -2.2 | -2.54 | -1.72 |
As % of sales | 10.62 | 11.47 | 8.34 |
Employee costs | -2.68 | -2.85 | -2.43 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Profit before tax | 3.3 | 0.71 | 0.22 |
Depreciation | -3.18 | -3.18 | -3.23 |
Tax paid | -0.99 | 0 | 0 |
Working capital | -3.88 | 6.08 | |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Growth matrix (%) | |||
Revenue growth | -6.26 | 7.64 | |
Op profit growth | 16.37 | -2.65 | |
EBIT growth | 51.76 | -10.41 | |
Net profit growth | 222.19 | 219.73 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 999.9 | 118.99 | 97,165.6 | 138.24 | 0.15 | 697.4 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,274.1 | 75.15 | 90,307.55 | 341.6 | 0.25 | 2,054.8 | 569.62 |
Fortis Healthcare Ltd FORTIS | 648.65 | 242.3 | 48,842.02 | 39.56 | 0.15 | 366.87 | 120.23 |
Global Health Ltd MEDANTA | 1,252.95 | 85.72 | 33,635.2 | 99.31 | 0 | 624.4 | 113.49 |
Narayana Hrudayalaya Ltd NH | 1,579.2 | 75.1 | 32,230.76 | 79.22 | 0.25 | 865.04 | 95.32 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Edwin Francis Dabre
Executive Director & CFO
Tejal Anil Jayakar
Non Executive Director
Krupesh Deepak Thakur
Independent Director
Nilesh Ghanshyam Bide
Independent Director
Abhinay Shashikant Nerurkar
Independent Director
Karim Hakam Khimani
Company Secretary
Akshay Joshi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Nidan Laboratories & Healthcare Ltd
Summary
Nidan Laboratories & Healthcare Limited was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 vide Certificate of Incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, Company name was changed from Abhi Diagnostic Imagings Private Limited to Nidan Laboratories And Healthcare Private Limited and obtained fresh Certificate of Incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, the status if the Company was converted into a Public Limited and name of the Company was changed to Nidan Laboratories And Healthcare Limited and a fresh Certificate of Incorporation upon the conversion to Public Limited Company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021. The Company carry on the business of Diagnostic Centre, such as X-Ray, Sonography, 2 D ECHO, PFT, CST, C.T. Scan, MRI etc., Blood Bank, Pathology Laboratories, Dialysis Unit, Intensive Care Unit, Burn & Poisoning Centre and Poly Clinic.Nidan was established as a Proprietary Firm in 1994 by Promoter, Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The Company came into existence in year 2000. The business was carried out under the sole proprietorship, which was later taken over by the Company in 2000. From the year 2000 onwards, he expanded the diagnostics business by setting up various cent
Read More
The Nidan Laboratories & Healthcare Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹22.5 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nidan Laboratories & Healthcare Ltd is ₹31.28 Cr. as of 06 Mar ‘25
The PE and PB ratios of Nidan Laboratories & Healthcare Ltd is 0 and 0.48 as of 06 Mar ‘25
The 52-week high/low is the highest and lowest price at which a Nidan Laboratories & Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Nidan Laboratories & Healthcare Ltd is ₹19.55 and ₹41.15 as of 06 Mar ‘25
Nidan Laboratories & Healthcare Ltd's CAGR for 5 Years at -28.18%, 3 Years at -16.96%, 1 Year at -29.69%, 6 Month at -32.63%, 3 Month at -20.21% and 1 Month at -4.86%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.